(Q24241326)

1

0 references

Ning Chen

2

0 references

Jie Yang

3

0 references

Muke Zhou

4

0 references

Dong Zhou

5

0 references

Quanwei Zhang

6

0 references

Li He

Cochrane Database of Systematic Reviews

7

0 references

publication date

15 April 2009

0 references

published in

0 references

cites work

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Oral acyclovir for herpes zoster ophthalmicus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

A double-masked, placebo-controlled trial of acyclovir cream in immunocompetent patients with herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Isoprinosine does not influence the natural history of herpes zoster or postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Limited value of acyclovir in the treatment of uncomplicated herpes zoster: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Clinical applications for change-point analysis of herpes zoster pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Clinical practice. Herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Post herpetic neuralgia: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Postherpetic neuralgia--pathogenesis, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Acute herpetic and postherpetic neuralgia: clinical review and current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Natural history of pain following herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Therapy of acute herpes zoster with acyclovir in the nonimmunocompromised host

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Proposed classification of herpes zoster pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Intravenous acyclovir in acute herpes zoster infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Prevention of post-herpetic neuralgia. Evaluation of treatment with oral prednisone, oral acyclovir, and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Effects of acyclovir on sensory axonal neuropathy, segmental motor paresis and postherpetic neuralgia in herpes zoster patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Oral acyclovir in herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006866.PUB2

7 January 2021